Mastodon

Vulnusan® (Ointment) Instructions for Use

Marketing Authorization Holder

Sopharma, JSC (Bulgaria)

ATC Code

D11AX (Other drugs used in dermatology)

Dosage Form

Bottle OTC Icon Vulnusan® Ointment for topical and external use 12 g/100 g: 45 g tube

Dosage Form, Packaging, and Composition

Ointment for topical and external use is homogeneous, ranging from light yellow to yellow in color, with a characteristic odor.

100 g
Pomorie Lake mother liquor (stabilized lye) 12 g

Excipients: Ricinus communis seed oil (castor oil) – 20 g, carmellose sodium – 3 g, lanolin – 32 g, sodium benzoate – 0.5 g, purified water – 32.5 g.

45 g – aluminum tubes (1) – cardboard packs.

Clinical-Pharmacological Group

A drug with anti-inflammatory, antimicrobial, and tissue regeneration-improving action

Pharmacotherapeutic Group

Topical anti-inflammatory agent of natural origin

Pharmacological Action

A topical agent of natural origin, obtained by processing the mother liquor of Pomorie Lake. It exerts anti-inflammatory, antimicrobial, and tissue regeneration-improving action.

The Pomorie Lake mother liquor contains macro- and microelements (magnesium, potassium, calcium, sodium, chlorine, bromine, iron, manganese, copper, cobalt, iodine, molybdenum, zinc, bismuth, selenium), as well as colloids, acids, alkalis, and other substances of organic origin.

Indications

Purulent wounds of various origins: infected, surgical, superficial purulent processes (including pararectal and post-injection abscesses), trophic ulcers, post-traumatic and atherosclerotic wounds; drug-induced skin maceration; ulcerations in Buerger’s disease, varicose ulcers, cervical erosion, fissures of the mammary gland nipple.

ICD codes

ICD-10 code Indication
I73.1 Obliterative thromboangiitis [Buerger's disease]
I83.2 Varicose veins of lower extremities with ulcer and inflammation
K60 Fissure and fistula of anus and rectum
K61 Abscess of anal and rectal regions
L02 Cutaneous abscess, furuncle and carbuncle
N64.0 Fissure and fistula of nipple
N86 Erosion and ectropion of cervix
T79.3 Posttraumatic wound infection, not elsewhere classified
ICD-11 code Indication
1B75.0 Furuncle
1B75.1 Carbuncle
1B75.2 Furunculosis
1B75.3 Pyogenic skin abscess
4A44.8 Thromboangiitis obliterans
BD74.Z Chronic venous insufficiency of lower extremities, unspecified
DB50.Z Fissure or fistula of anal region, unspecified
DB70.0Z Abscess of anal and rectal region, unspecified
DE2Z Diseases of the digestive system, unspecified
GA15.1 Erosion or ectropion of cervix
GB23.1 Fissure or fistula of nipple
NF0A.3 Posttraumatic wound infection, not elsewhere classified

Dosage Regimen

The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen.

Apply externally to the affected area after thorough cleansing and drying.

For purulent wounds, trophic ulcers, and post-traumatic wounds, apply a thin layer of ointment 1 to 2 times daily.

For superficial purulent processes such as abscesses and furuncles, apply directly to the lesion once or twice daily.

In cases of cervical erosion or nipple fissures, apply the ointment carefully to the affected site once daily.

Use a sterile gauze dressing to cover the treated area after application.

Change the dressing and reapply the ointment according to the severity of the condition and the amount of exudate.

The duration of treatment is determined by the rate of tissue regeneration and clinical response.

Discontinue use and consult a physician if allergic reactions such as skin rash or urticaria occur.

Avoid contact with eyes and mucous membranes. Wash hands thoroughly before and after application.

Adverse Reactions

Allergic reactions skin rash, urticaria, angioedema.

Local reactions pain upon application to ulcers.

Contraindications

Pregnancy; children under 12 years of age; hypersensitivity to the active substance.

Use in Pregnancy and Lactation

Use is contraindicated during pregnancy.

Use of this product during lactation is possible according to indications. Use does not interfere with feeding the child and does not require discontinuation of breastfeeding.

Pediatric Use

Contraindication: children under 12 years of age.

Special Precautions

If necessary, it can be used with occlusive dressings.

Storage Conditions

Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.

Dispensing Status

Over-the-Counter

Important Safety Information

This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.

Medical Disclaimer

TABLE OF CONTENTS